Enzo Biochem Stock Probability of Future Stock Price Finishing Over 1.08
| ENZ Stock | USD 1.08 0.05 4.85% |
Enzo |
Enzo Biochem Target Price Odds to finish over 1.08
The tendency of Enzo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.08 | 90 days | 1.08 | near 1 |
Based on a normal probability distribution, the odds of Enzo Biochem to move above the current price in 90 days from now is near 1 (This Enzo Biochem probability density function shows the probability of Enzo Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Enzo Biochem has a beta of 0.38 suggesting as returns on the market go up, Enzo Biochem average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Enzo Biochem will be expected to be much smaller as well. Additionally Enzo Biochem has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Enzo Biochem Price Density |
| Price |
Predictive Modules for Enzo Biochem
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enzo Biochem. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Enzo Biochem Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Enzo Biochem is not an exception. The market had few large corrections towards the Enzo Biochem's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Enzo Biochem, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Enzo Biochem within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.01 | |
β | Beta against Dow Jones | 0.38 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | -0.05 |
Enzo Biochem Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Enzo Biochem for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Enzo Biochem can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Enzo Biochem has some characteristics of a very speculative penny stock | |
| The company reported the last year's revenue of 31.91 M. Reported Net Loss for the year was (26.08 M) with profit before taxes, overhead, and interest of 11.57 M. | |
| Enzo Biochem has about 82.37 M in cash with (26.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44. | |
| Roughly 22.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: 100,000 Shares in Enzo Biochem, Inc. Bought by BBR Partners LLC |
Enzo Biochem Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Enzo Stock often depends not only on the future outlook of the current and potential Enzo Biochem's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enzo Biochem's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 50.9 M | |
| Cash And Short Term Investments | 52.4 M |
Enzo Biochem Technical Analysis
Enzo Biochem's future price can be derived by breaking down and analyzing its technical indicators over time. Enzo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Enzo Biochem. In general, you should focus on analyzing Enzo Stock price patterns and their correlations with different microeconomic environments and drivers.
Enzo Biochem Predictive Forecast Models
Enzo Biochem's time-series forecasting models is one of many Enzo Biochem's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Enzo Biochem's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Enzo Biochem
Checking the ongoing alerts about Enzo Biochem for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Enzo Biochem help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Enzo Biochem has some characteristics of a very speculative penny stock | |
| The company reported the last year's revenue of 31.91 M. Reported Net Loss for the year was (26.08 M) with profit before taxes, overhead, and interest of 11.57 M. | |
| Enzo Biochem has about 82.37 M in cash with (26.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44. | |
| Roughly 22.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: 100,000 Shares in Enzo Biochem, Inc. Bought by BBR Partners LLC |
Additional Tools for Enzo Stock Analysis
When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.